MEDIROM Healthcare Technologies Inc - ADR Stock

$3.02

6.79% yesterday

Nasdaq, Sep 27, 10:00 pm CET

ISIN

US58510H1032

Symbol

MRM

Reports

Quarter | Annual

Index

NASDAQ Composite

Overview Dividends Analysts Charts News Strategies

MEDIROM Healthcare Technologies Inc - ADR Stock price

$3.02

-11.98 79.87% 5Y

Nasdaq, Closing price Fri, Sep 27 2024

-0.22 6.79%

ISIN

US58510H1032

Symbol

MRM

Reports

Quarter | Annual

Index

NASDAQ Composite

Key metrics

Market capitalization	$15.82m
Enterprise Value	$40.81m
P/E (TTM) P/E ratio	26.96
EV/FCF (TTM) EV/FCF	negative
EV/Sales (TTM) EV/Sales	0.84
P/S ratio (TTM) P/S ratio	0.33
P/B ratio (TTM) P/B ratio	10.58
Revenue growth (TTM) Revenue growth	-8.04%
Revenue (TTM) Revenue	$48.55m
EBIT (operating result TTM) EBIT	$-2.86m
Free Cash Flow (TTM) Free Cash Flow	$-5.25m
EPS (TTM) EPS	$0.12
Short interest	2.18%

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Get Started for Free Today

MEDIROM Healthcare Technologies Inc - ADR Stock Analysis

Unlock Scores for Free

??

Financial data from MEDIROM Healthcare Technologies Inc - ADR

Income Statement P&L | Balance Sheet | Cash Flow

TTM Annually

Dec '23		+/- %
Revenue	49 49	- 100%
- Direct Costs	37 37	- 77%
Gross Profit	11 11	- 23%
- Selling and Administrative Expenses	12 12	- 25%
- Research and Development Expense	- -	- -
EBITDA	-1.07 -1.07	- -2%
- Depreciation and Amortization	1.79 1.79	- 4%
EBIT (Operating Income) EBIT	-2.86 -2.86	- -6%
Net Profit	0.59 0.59	- 1%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

MEDIROM Healthcare Technologies Inc - ADR Stock News

Neutral

GlobeNewsWire

●

about one month ago

Capital and Business Alliance Formed Between MEDIROM MOTHER Labs and NFES Technologies

NFES Group Selected as Lead Investor in Series A Round Valued at 9 Billion Yen NFES Group Selected as Lead Investor in Series A Round Valued at 9 Billion Yen

Neutral

GlobeNewsWire

●

2 months ago

MEDIROM Healthcare Technologies Announces Business Transfer from Y's, Inc.

TOKYO, July 22, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (“we”, “our”, “us” or “the Company”) hereby announces that its subsidiary MEDIROM Rehab Solutions Inc. entered into an agreement to purchase a rehabilitation business from Y's, Inc., a Japanese corporation, as of July 10, 2024.

Neutral

GlobeNewsWire

●

3 months ago

MEDIROM Healthcare Technologies Announces Acquisition of Japan Gene Medicine Corporation

NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (“we”, “our”, “us” or “the Company”) hereby announces that the Company plans to acquire a majority of Japan Gene Medicine Corporation (the “Target Company”). On June 30, 2024, the Company entered into a share transfer agreement (the "Share Transfer Agreement") to acquire 70.0% of the shares of the Target Company fr...

More MEDIROM Healthcare Technologies Inc - ADR News

Company Profile

MEDIROM Healthcare Technologies, Inc. owns, develops, operates, manages, and supports relaxation salons through the franchising and direct ownership of such salons. It provides relaxation and bodywork services. The firm operates two synergistic lines of businesses: Relaxation Salon Segment (retail) and Digital Preventative Healthcare Segment (healthtech). The company was founded by Kouji Eguchi in July 2000 and is headquartered in Tokyo, Japan.

Head office	Japan
CEO	Koji Eguchi
Employees	1,101
Founded	2000
Website	www.medirom.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now